Abstract |
|
Authors | S A Holden, B A Teicher, M F Robinson, D Northey, A Rosowsky |
Journal | Cancer chemotherapy and pharmacology
(Cancer Chemother Pharmacol)
Vol. 36
Issue 2
Pg. 165-71
( 1995)
ISSN: 0344-5704 [Print] Germany |
PMID | 7767954
(Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antineoplastic Agents
- DNA, Neoplasm
- Folic Acid Antagonists
- Pterins
- Topoisomerase II Inhibitors
- N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
- Novobiocin
- Etoposide
- Ornithine
- Trimetrexate
- Methotrexate
|
Topics |
- Animals
- Antineoplastic Agents
(therapeutic use, toxicity)
- Carcinoma, Squamous Cell
(drug therapy)
- Cell Division
(drug effects)
- Cell Line
- Cell Survival
(drug effects)
- DNA Damage
- DNA, Neoplasm
(drug effects)
- Drug Synergism
- Etoposide
(therapeutic use, toxicity)
- Folic Acid Antagonists
(therapeutic use, toxicity)
- Head and Neck Neoplasms
- Humans
- Male
- Methotrexate
(therapeutic use, toxicity)
- Mice
- Mice, Inbred C3H
- Novobiocin
(therapeutic use, toxicity)
- Ornithine
(analogs & derivatives, therapeutic use, toxicity)
- Pterins
(therapeutic use, toxicity)
- Topoisomerase II Inhibitors
- Trimetrexate
(therapeutic use, toxicity)
- Tumor Cells, Cultured
|